BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1692983)

  • 1. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities.
    Stiller RJ; de Regt RH; Suntag S; Baumgarten A; Hobbins JC; Mahoney MJ
    Obstet Gynecol; 1990 Jun; 75(6):994-7. PubMed ID: 1692983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
    Warner AA; Pettenati MJ; Burton BK
    Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic use of meternal serum alpha-fetoprotein levels.
    Cowchock FS; Jackson LG
    Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.
    Megerian G; Godmilow L; Donnenfeld AE
    Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of aneuploidy and unexplained elevated maternal serum alpha-fetoprotein.
    Hiett AK; Callaghan CM; Brown HL; Golichowski AM; Heerema NA
    J Perinatol; 1998; 18(5):343-6. PubMed ID: 9766408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amniotic fluid alpha-fetoprotein and acetylcholinesterase in early genetic amniocentesis.
    Drugan A; Syner FN; Greb A; Evans MI
    Obstet Gynecol; 1988 Jul; 72(1):35-8. PubMed ID: 2454439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of elevations in maternal serum alpha-fetoprotein: a review.
    Thomas RL; Blakemore KJ
    Obstet Gynecol Surv; 1990 May; 45(5):269-83. PubMed ID: 1692399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
    Kaffe S; Hsu LY
    Am J Med Genet; 1992 Apr; 42(6):801-6. PubMed ID: 1372793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The usefulness of the level of alpha-fetoprotein (AFP) and electrophoresis of amniotic acetylcholinesterase for the detection of selected congenital malformations].
    Lemonnier MC; Julian C; Aymé S; Philip N; Voeckel MA; Gamerre M; Mattéi JF
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(3):280-4. PubMed ID: 1693158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A normal ultrasound does not obviate the need for amniocentesis in patients with elevated serum alpha-fetoprotein.
    Drugan A; Zador IE; Syner FN; Sokol RJ; Sacks AJ; Evans MI
    Obstet Gynecol; 1988 Oct; 72(4):627-30. PubMed ID: 2458560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
    Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
    Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
    Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD; Owen J; Davis RO; Brumfield CG
    Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities.
    Chescheir NC; Katz VL; Thorp JM; Watson WJ; Lingley LH
    Obstet Gynecol; 1990 Nov; 76(5 Pt 1):893-4. PubMed ID: 1699184
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
    Grau P; Robinson L; Tabsh K; Crandall BF
    Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is routine fetal karyotyping necessary for patients undergoing amniocentesis for elevated maternal serum alpha-fetoprotein?
    Gonzalez D; Barrett T; Apuzzio J
    J Matern Fetal Med; 2001 Dec; 10(6):376-9. PubMed ID: 11798446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
    Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.